FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1487841297> ?p ?o ?g. }

• W1487841297 endingPage "514" @default.
• W1487841297 startingPage "508" @default.
• W1487841297 abstract "Portal hypertension is a common complication of chronic liver disease. Its relevance comes from the fact that it determines most complications leading to death or liver transplantation in patients with cirrhosis of the liver: bleeding from esophageal or gastric varices, ascites and renal dysfunction, sepsis and hepatic encephalopathy. Portal hypertension results from increased resistance to portal blood flow through the cirrhotic liver. This is caused by two mechanisms: (1) distortion of the liver vascular architecture due to the liver disease causing structural abnormalities (nodule formation, remodeling of liver sinusoids, fibrosis, angiogenesis and vascular occlusion), and (2) increased hepatic vascular tone due to sinusoidal endothelial dysfunction, which results in a defective production of endogenous vasodilators, mainly nitric oxide (NO), and increased production of vasoconstrictors (thromboxane A2, cysteinyl leukotrienes, angiotensin II, endothelins and an activated adrenergic system). Hepatic endothelial dysfunction occurs early in the course of chronic liver disease as a consequence of inflammation and oxidative stress, and determines loss of the normal phenotype of liver sinusoidal endothelial cells (LSECs) that become proliferative, prothrombotic, proinflammatory and vasoconstrictor. The cross-talk between LSECs and hepatic stellate cells (HSCs) induces activation of the latter, which in turn proliferate, migrate and increase collagen deposition around the sinusoids, contributing to fibrogenesis, architectural disruption and angiogenesis, which further increase the hepatic vascular resistance and worsen liver failure by interfering with the blood perfusion of the liver parenchyma. An additional factor further worsening portal hypertension is an increased blood flow through the portal system due to splanchnic vasodilatation. This is an adaptive response to decreased effective hepatocyte perfusion, and is maximal once portal pressure has increased sufficiently to promote the development of intrahepatic shunts and portal-systemic collaterals, including varices, through which portal blood flow bypasses the liver. In human portal hypertension collateralization and hyperdynamic circulation start at a portal pressure gradient >10 mm Hg. Rational therapy for portal hypertension aims at correcting these pathophysiological abnormalities: liver injury, fibrogenesis, increased hepatic vascular tone and splanchnic vasodilatation. Continuing liver injury may be counteracted specifically by etiological treatments (the best example being the direct-acting antivirals for hepatitis C viral infection), while architectural disruption and fibrosis can be ameliorated by a variety of antifibrotic drugs and antiangiogenic strategies. Several drugs in this category are currently under investigation in phase II-III randomized controlled trials. Sinusoidal endothelial dysfunction is ameliorated by statins as well as by other drugs increasing NO availability. It is of note that simvastatin has already been proven to be clinically effective in two randomized controlled trials. Splanchnic hyperemia can be counteracted by nonselective β-blockers (NSBBs), vasopressin analogs and somatostatin analogs, drugs that until recently were the only available treatments for portal hypertension, but that are not very effective in the initial stages of cirrhosis. There is experimental and clinical evidence indicating that a more effective reduction of portal pressure is obtained by combining agents acting on these different pathways. It is likely that the treatment of portal hypertension will evolve to use etiological treatments together with antifibrotic agents and/or drugs improving sinusoidal endothelial function in the initial stages of cirrhosis (preprimary prophylaxis), while NSBBs will be added in advanced stages of the disease." @default.
• W1487841297 created "2016-06-24" @default.
• W1487841297 creator A5008480476 @default.
• W1487841297 creator A5012387403 @default.
• W1487841297 creator A5037822431 @default.
• W1487841297 date "2015-01-01" @default.
• W1487841297 modified "2023-10-06" @default.
• W1487841297 title "Pathophysiology and a Rational Basis of Therapy" @default.
• W1487841297 cites W1545032870 @default.
• W1487841297 cites W1974834526 @default.
• W1487841297 cites W1977983569 @default.
• W1487841297 cites W1978252369 @default.
• W1487841297 cites W1981077073 @default.
• W1487841297 cites W1986332326 @default.
• W1487841297 cites W1990139802 @default.
• W1487841297 cites W1997485766 @default.
• W1487841297 cites W1997652125 @default.
• W1487841297 cites W2001327300 @default.
• W1487841297 cites W2011370722 @default.
• W1487841297 cites W2012030428 @default.
• W1487841297 cites W2014616693 @default.
• W1487841297 cites W2015097141 @default.
• W1487841297 cites W2016751268 @default.
• W1487841297 cites W2018103937 @default.
• W1487841297 cites W2019177485 @default.
• W1487841297 cites W2025189929 @default.
• W1487841297 cites W2035704373 @default.
• W1487841297 cites W2040605044 @default.
• W1487841297 cites W2040610336 @default.
• W1487841297 cites W2041553454 @default.
• W1487841297 cites W2048676222 @default.
• W1487841297 cites W2049864335 @default.
• W1487841297 cites W2060148370 @default.
• W1487841297 cites W2060893815 @default.
• W1487841297 cites W2062557346 @default.
• W1487841297 cites W2066273470 @default.
• W1487841297 cites W2066542029 @default.
• W1487841297 cites W2066995998 @default.
• W1487841297 cites W2067719505 @default.
• W1487841297 cites W2070545304 @default.
• W1487841297 cites W2071840858 @default.
• W1487841297 cites W2078179573 @default.
• W1487841297 cites W2080610214 @default.
• W1487841297 cites W2083266053 @default.
• W1487841297 cites W2084279947 @default.
• W1487841297 cites W2091800777 @default.
• W1487841297 cites W2092881530 @default.
• W1487841297 cites W2093363685 @default.
• W1487841297 cites W2097100895 @default.
• W1487841297 cites W2097157805 @default.
• W1487841297 cites W2099069267 @default.
• W1487841297 cites W2100258257 @default.
• W1487841297 cites W2103953707 @default.
• W1487841297 cites W2109692351 @default.
• W1487841297 cites W2121848682 @default.
• W1487841297 cites W2126903895 @default.
• W1487841297 cites W2133662506 @default.
• W1487841297 cites W2151504267 @default.
• W1487841297 cites W2154139409 @default.
• W1487841297 cites W2158129157 @default.
• W1487841297 cites W2158132208 @default.
• W1487841297 cites W2162226128 @default.
• W1487841297 cites W2165726528 @default.
• W1487841297 cites W2166360182 @default.
• W1487841297 cites W4210986718 @default.
• W1487841297 cites W4232941745 @default.
• W1487841297 doi "https://doi.org/10.1159/000374099" @default.
• W1487841297 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26159267" @default.
• W1487841297 hasPublicationYear "2015" @default.
• W1487841297 type Work @default.
• W1487841297 sameAs 1487841297 @default.
• W1487841297 citedByCount "15" @default.
• W1487841297 countsByYear W14878412972015 @default.
• W1487841297 countsByYear W14878412972016 @default.
• W1487841297 countsByYear W14878412972017 @default.
• W1487841297 countsByYear W14878412972018 @default.
• W1487841297 countsByYear W14878412972020 @default.
• W1487841297 countsByYear W14878412972021 @default.
• W1487841297 countsByYear W14878412972022 @default.
• W1487841297 countsByYear W14878412972023 @default.
• W1487841297 crossrefType "journal-article" @default.
• W1487841297 hasAuthorship W1487841297A5008480476 @default.
• W1487841297 hasAuthorship W1487841297A5012387403 @default.
• W1487841297 hasAuthorship W1487841297A5037822431 @default.
• W1487841297 hasConcept C126322002 @default.
• W1487841297 hasConcept C134018914 @default.
• W1487841297 hasConcept C142724271 @default.
• W1487841297 hasConcept C176891718 @default.
• W1487841297 hasConcept C2777214474 @default.
• W1487841297 hasConcept C2778808290 @default.
• W1487841297 hasConcept C2779102576 @default.
• W1487841297 hasConcept C2780972559 @default.
• W1487841297 hasConcept C56900294 @default.
• W1487841297 hasConcept C71924100 @default.
• W1487841297 hasConceptScore W1487841297C126322002 @default.
• W1487841297 hasConceptScore W1487841297C134018914 @default.
• W1487841297 hasConceptScore W1487841297C142724271 @default.
• W1487841297 hasConceptScore W1487841297C176891718 @default.

• next